For research use only. Not for therapeutic Use.
AChE-IN-26 (compound 4a) is an AChE (acetylcholinesterase) inhibitor with an IC50 value of 0.42 μM. AChE-IN-26 can be used for the research of Alzheimer’s disease[1].
AChE-IN-26 (1 and 10 μM;20 min) shows an in-vitro inhibition to AChE of 91.45%, and inhibits AChE with an IC50 value of 0.42 μM[1].
Catalog Number | I042826 |
CAS Number | 2977170-10-6 |
Synonyms | N-(1-benzylpyridin-1-ium-4-yl)-3,4-dimethoxybenzamide;bromide |
Molecular Formula | C21H21BrN2O3 |
Purity | ≥95% |
InChI | InChI=1S/C21H20N2O3.BrH/c1-25-19-9-8-17(14-20(19)26-2)21(24)22-18-10-12-23(13-11-18)15-16-6-4-3-5-7-16;/h3-14H,15H2,1-2H3;1H |
InChIKey | VGTPSQFSPGENRA-UHFFFAOYSA-N |
SMILES | COC1=C(C=C(C=C1)C(=O)NC2=CC=[N+](C=C2)CC3=CC=CC=C3)OC.[Br-] |
Reference | [1]. Abdullaha M, et al. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase. Eur J Med Chem. 2020 Dec 1;207:112761. |